HR 4369 · 117th Congress · Health
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Bill Progress
✓
Introduced✓
Committee✓
House Vote4
Senate5
EnactedLatest: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2021-10-20)
Recorded Votes
How Did Your Rep Vote?
Enter a ZIP code or representative's name
Plain Language Summary
[AI summary unavailable — showing source text]
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 4369, National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Oct 25, 2021As passed by the House of Representatives on October 19, 2021
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office